Literature DB >> 7675965

Sulpiride antagonizes the biphasic locomotor effects of quinpirole in weanling rats.

K J Frantz1, C Van Hartesveldt.   

Abstract

Low doses of dopamine (DA) agonists such as the D2 receptor subfamily agonist quinpirole are thought to stimulate DA autoreceptors selectively, thereby inhibiting locomotor activity. High doses of quinpirole initially suppress and later activate locomotion during a single test-session; the activation is presumably due to stimulation of postsynaptic receptors. The aim of this study was to investigate whether pretreatment with a selective DA D2 receptor antagonist, sulpiride, could block the putative autoreceptor-mediated inhibition at a lower dose than was required to block the postsynaptically mediated activation. Male and female 30-day-old rats were injected SC with one of eight doses of sulpiride (0.313-40 mg/kg) or the vehicle. Sixty minutes later, rats were injected SC with 0.2 mg/kg quinpirole or the vehicle. Five minutes after the second injection, rats were placed in automated activity monitors which recorded locomotor behavior for 60 min at 5-min intervals. Quinpirole at this dose first suppressed and later increased locomotor activity. Sulpiride pretreatment dose-dependently reversed both the early inhibition and later activation of quinpirole-induced locomotion. However, sulpiride did not block the quinpirole-induced early suppression at a lower dose than was required to block the later activation. Thus, there was no evidence that the locomotor suppression elicited by quinpirole is mediated by a more sensitive subset of DA receptors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7675965     DOI: 10.1007/bf02246295

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  25 in total

1.  Effects of intracerebral quinpirole on locomotion in rats.

Authors:  C Van Hartesveldt; G A Cottrell; T Potter; M E Meyer
Journal:  Eur J Pharmacol       Date:  1992-04-07       Impact factor: 4.432

2.  Anxiolytic potential of sulpiride, clozapine and derivatives in the open-field test.

Authors:  J Bruhwyler; E Chleide; J F Liégeois; J Delarge; M Mercier
Journal:  Pharmacol Biochem Behav       Date:  1990-05       Impact factor: 3.533

3.  Differential actions of substituted benzamides on pre- and postsynaptic dopamine receptor mechanisms in the nucleus accumbens.

Authors:  B Costall; S C Hui; R J Naylor
Journal:  J Pharm Pharmacol       Date:  1980-08       Impact factor: 3.765

4.  Neuroleptic antagonism of the motor inhibitory effects of apomorphine within the nucleus accumbens: drug interaction at presynaptic receptors?

Authors:  B Costall; D H Fortune; S C Hui; R J Naylor
Journal:  Eur J Pharmacol       Date:  1980-05-16       Impact factor: 4.432

5.  Ontogeny of biphasic locomotor effects of quinpirole.

Authors:  C Van Hartesveldt; M E Meyer; T J Potter
Journal:  Pharmacol Biochem Behav       Date:  1994-07       Impact factor: 3.533

6.  Inhibition of dopamine synthesis in striatal synaptosomes by lisuride: stereospecific reversal by (-)-sulpiride.

Authors:  A H Tissari; L Atzori; M T Galdieri
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-02       Impact factor: 3.000

7.  Time course of rat motility response to apomorphine: a simple model for studying preferential blockade of brain dopamine receptors mediating sedation.

Authors:  N Montanaro; A Vaccheri; R Dall'Olio; O Gandolfi
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

8.  Development of dopamine autoreceptors in the postnatal rat brain.

Authors:  T Hedner; P Lundborg
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

9.  Dopamine D2 autoreceptors in rats are behaviorally functional at 21 but not 10 days of age.

Authors:  M Y Lin; D E Walters
Journal:  Psychopharmacology (Berl)       Date:  1994-03       Impact factor: 4.530

10.  Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain.

Authors:  U Strömbom
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

View more
  5 in total

1.  Low dose effects in psychopharmacology: ontogenetic considerations.

Authors:  Linda Patia Spear; Elena I Varlinskaya
Journal:  Nonlinearity Biol Toxicol Med       Date:  2005-01

2.  Caffeine promotes dopamine D1 receptor-mediated body temperature, heart rate and behavioural responses to MDMA ('ecstasy').

Authors:  Natacha Vanattou-Saïfoudine; Ruth McNamara; Andrew Harkin
Journal:  Psychopharmacology (Berl)       Date:  2010-05-02       Impact factor: 4.530

3.  Mesolimbic dopamine super-sensitivity in melanin-concentrating hormone-1 receptor-deficient mice.

Authors:  Daniel G Smith; Eleni T Tzavara; Janice Shaw; Susan Luecke; Mark Wade; Richard Davis; Craig Salhoff; George G Nomikos; Donald R Gehlert
Journal:  J Neurosci       Date:  2005-01-26       Impact factor: 6.167

4.  Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions.

Authors:  Y Wang; R Xu; T Sasaoka; S Tonegawa; M P Kung; E B Sankoorikal
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

5.  Examining the role of paraoxonase 2 in the dopaminergic system of the mouse brain.

Authors:  Jacqueline M Garrick; Khoi Dao; Lucio G Costa; Judit Marsillach; Clement E Furlong
Journal:  BMC Neurosci       Date:  2022-09-02       Impact factor: 3.264

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.